SWK logo
SWK
SWKH | NASDAQ
Chart Builder DCF Calculator
$15.90
$0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM ET

SWK Company Profile

Company profile explained

Company Profile

SWK Holdings Corporation (SWKH) operates as a specialized financial institution, primarily concentrating its efforts within the healthcare sector. The company's operations are distinctly divided into two core segments: Finance Receivables and Pharmaceutical Development. Within its finance division, SWK offers bespoke funding solutions tailored to a diverse array of life science enterprises. These include companies spanning biotechnology, medical devices, diagnostic tools, animal health, and pharmaceuticals, alongside various institutions and individual innovators. Furthermore, the company extends non-discretionary investment advisory services, managing separate accounts for institutional clients keen on investing in the life science finance domain. Its Pharmaceutical Development segment involves the creation, formulation, production, and licensing of pharmaceutical products, leveraging its proprietary Peptelligence platform. A key strategic objective here is to license its internally developed product pipeline to external partners, aiming to generate innovative formulations through its unique technology, ultimately designed to benefit patients and their caregivers. Founded in 1996, the company underwent a name change from Kana Software, Inc. to SWK Holdings Corporation in December 2009. Its corporate headquarters are situated in Dallas, Texas.

Key Executives

Name Position
Jody Staggs Chief Executive Officer & President
Adam Christopher Rice Chief Financial Officer
Courtney Baker Controller
David R. Earhart General Counsel & Secretary
John David Tamas Director of Underwriting
Kendall Bardin Director of HR
Michael Miner Vice President
Peter Blumberg Vice President of Originations

Latest SEC Filings

Date Type Title
Apr 23, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Apr 16, 2026 15-12G Filing
Apr 08, 2026 EFFECT Filing
Apr 08, 2026 EFFECT Filing
Apr 08, 2026 SC 13D/A [Amend] Filing
Apr 08, 2026 4 Filing
Apr 07, 2026 S-8 POS Filing
Apr 07, 2026 S-8 POS Filing
Apr 07, 2026 S-8 POS Filing
Apr 07, 2026 S-8 POS Filing
View All SEC Filings ➞
SWK
SWK logo
Country United States
IPO Date Sep 23, 1999
Industry Asset Management
Sector Financial Services
Employees 24
CEO Jody. D Staggs

Contact Details

14755 Preston Road Dallas, Texas 75254 United States

Stock Details

Ticker Symbol SWKH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001089907
CUSIP Number 78501P203
ISIN Number US78501P2039
SIC Code 6159

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.